Hepatitis C-associated mixed cryoglobulinemic vasculitis induces differential gene expression in peripheral mononuclear cells

Frontiers in Immunology

Volumn 5, Issue MAY, 2014, Pages

  Sidharthan, Sreetha ^a   Kim, Cheol Woo ^b   Murphy, Alison A ^c   Zhang, Xiaozhen ^c   Yang, Jun ^d   Lempicki, Richard A ^d   Sneller, Michael C ^c   Kottilil, Shyam ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b Inha University   (South Korea)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

Author keywords

Hepatitis C; Interferon stimulated genes; Mixed cryoglobulinemia; Vasculitis

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; CRYOGLOBULINEMIA VASCULITIS; FEMALE; GENE; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON STIMULATED GENE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MONOCYTE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULITIS;

EID: 84905384479     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00248     Document Type: Article

References (30)

1. Hadigan C, Kottilil S. Hepatitis C virus infection and coinfection with human immunodeficiency virus: challenges and advancements in management. JAMA (2011) 306:294-301. doi:10.1001/jama.2011.975
2. Ashfaq UA, Javed T, Rehman S, Nawaz Z, Riazuddin S. An overview of HCV molecular biology, replication and immune responses. Virol J (2011) 8:161. doi:10.1186/1743-422X-8-161
3. National institutes of health consensus development conference statement: management of hepatitis C 2002 (June 10-12, 2002). Gastroenterology (2002) 123:2082-99. doi:10.1053/gast.2002.1232082
4. Jacobson IM, Cacoub P, Dal Maso L, Harrison SA, Younossi ZM. Manifestations of chronic hepatitis C virus infection beyond the liver. Clin Gastroenterol Hepatol (2010) 8:1017-29. doi:10.1016/j.cgh.2010.08.026
5. Galossi A, Guarisco R, Bellis L, Puoti C. Extrahepatic manifestations of chronic HCV infection. J Gastrointestin Liver Dis (2007) 16:65-73.
6. Dore MP, Fattovich G, Sepulveda AR, Realdi G. Cryoglobulinemia related to hepatitis C virus infection. Dig Dis Sci (2007) 52:897-907. doi:10.1007/s10620-006-9510-9
7. Ferri C, La Civita L, Longombardo G, Greco F, Bombardieri S. Hepatitis C virus and mixed cryoglobulinaemia. Eur J Clin Invest (1993) 23:399-405. doi:10.1111/j.1365-2362.1993.tb00782.x
8. Saadoun D, Bieche I, Maisonobe T, Asselah T, Laurendeau I, Piette JC, et al. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum (2005) 52:2917-25. doi:10.1002/art.21270
9. Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol (2006) 18:54-63.
10. Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum (1999) 42:2507-16. doi:10.1002/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-
11. Antonelli A, Ferri C, Galeazzi M, Giannitti C, Manno D, Mieli-Vergani G, et al. HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol (2008) 26:S39-47.
12. Saadoun D, Delluc A, Piette JC, Cacoub P. Treatment of hepatitis C-associated mixed cryoglobulinemia vasculitis. Curr Opin Rheumatol (2008) 20:23-8. doi:10.1097/BOR.0b013e3282f1330c
13. Sneller MC, Hu Z, Langford CA. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum (2012) 64:835-42. doi:10.1002/art.34322
14. Kottilil S, Yan MY, Reitano KN, Zhang X, Lempicki R, Roby G, et al. Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells. Hepatology (2009) 50:34-45. doi:10.1002/hep.23055
15. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 3:710-20. doi:10.1038/nri1180
16. Rodriguez-Garcia M, Climent N, Oliva H, Casanova V, Franco R, Leon A, et al. Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression. PLoS One (2010) 5:e9436. doi:10.1371/journal.pone.0009436
17. Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol (2006) 7:243. doi:10.1186/gb-2006-7-12-243
18. Lee SC, Brummet ME, Shahabuddin S, Woodworth TG, Georas SN, Leiferman KM, et al. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J Immunol (2000) 164:3392-401. doi:10.4049/jimmunol.164.6.3392
19. De Filippo K, Dudeck A, Hasenberg M, Nye E, van Rooijen N, Hartmann K, et al. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood (2013) 121:4930-7. doi:10.1182/blood-2013-02-486217
20. Shinoda K, Tokoyoda K, Hanazawa A, Hayashizaki K, Zehentmeier S, Hosokawa H, et al. Type II membrane protein CD69 regulates the formation of resting T-helper memory. Proc Natl Acad Sci U S A (2012) 109:7409-14. doi:10.1073/pnas.1118539109
21. Ishibashi M, Wakita T, Esumi M. 2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro. Biochem Biophys Res Commun (2010) 392:397-402. doi:10.1016/j.bbrc.2010.01.034
22. Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, Trepo C, et al. Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol (2012) 2012:231210. doi:10.1155/2012/231210
23. Childs KS, Goodbourn S. Identification of novel co-repressor molecules for interferon regulatory factor-2. Nucleic Acids Res (2003) 31:3016-26. doi:10.1093/nar/gkg431
24. Matloubian M, David A, Engel S, Ryan JE, Cyster JG. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat Immunol (2000) 1:298-304. doi:10.1038/79738
25. Chen Y, Chen J, Wang H, Shi J, Wu K, Liu S, et al. HCV-induced miR-21 contributes to evasion of host immune system by targeting MyD88 and IRAK1. PLoS Pathog (2013) 9:e1003248. doi:10.1371/journal.ppat.1003248
26. Larrea E, Riezu-Boj JI, Aldabe R, Guembe L, Echeverria I, Balasiddaiah A, et al. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes. Gut (2013) 63(4):665-73. doi:10.1136/gutjnl-2012-304377
27. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) (2000) 79:47-56. doi:10.1097/00005792-200001000-00005
28. Oo YH, Banz V, Kavanagh D, Liaskou E, Withers DR, Humphreys E, et al. CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver. J Hepatol (2012) 57:1044-51. doi:10.1016/j.jhep.2012.07.008
29. Chen L, Borozan I, Feld J, Sun J, Tannis LL, Coltescu C, et al. Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology (2005) 128:1437-44. doi:10.1053/j.gastro.2005.01.059
30. Lempicki RA, Polis MA, Yang J, McLaughlin M, Koratich C, Huang DW, et al. Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. J Infect Dis (2006) 193:1172-7. doi:10.1086/501365